Abstract
Evidence suggests that accumulation and aggregation of α-synuclein contribute to the pathogenesis of Parkinson’s disease (PD). The aim of this study was to evaluate whether diffusion kurtosis imaging (DKI) will provide a sensitive tool for differentiating between α-synuclein-overexpressing transgenic mouse model of PD (TNWT-61) and wild-type (WT) littermates. This experiment was designed as a proof-of-concept study and forms a part of a complex protocol and ongoing translational research. Nine-month-old TNWT-61 mice and age-matched WT littermates underwent behavioral tests to monitor motor impairment and MRI scanning using 9.4 Tesla system in vivo. Tract-based spatial statistics (TBSS) and the DKI protocol were used to compare the whole brain white matter of TNWT-61 and WT mice. In addition, region of interest (ROI) analysis was performed in gray matter regions such as substantia nigra, striatum, hippocampus, sensorimotor cortex, and thalamus known to show higher accumulation of α-synuclein. For the ROI analysis, both DKI (6 b-values) protocol and conventional (2 b-values) diffusion tensor imaging (cDTI) protocol were used. TNWT-61 mice showed significant impairment of motor coordination. With the DKI protocol, mean, axial, and radial kurtosis were found to be significantly elevated, whereas mean and radial diffusivity were decreased in the TNWT-61 group compared to that in the WT controls with both TBSS and ROI analysis. With the cDTI protocol, the ROI analysis showed decrease in all diffusivity parameters in TNWT-61 mice. The current study provides evidence that DKI by providing both kurtosis and diffusivity parameters gives unique information that is complementary to cDTI for in vivo detection of pathological changes that underlie PD-like symptomatology in TNWT-61 mouse model of PD. This result is a crucial step in search for a candidate diagnostic biomarker with translational potential and relevance for human studies.
Similar content being viewed by others
References
Blockx I, Verhoye M, Van Audekerke J, Bergwerf I, Kane JX, Delgado YPR, Veraart J, Jeurissen B, Raber K, von Horsten S, Ponsaerts P, Sijbers J, Leergaard TB, Van der Linden A (2012) Identification and characterization of Huntington related pathology: an in vivo DKI imaging study. NeuroImage 63(2):653–662
Boska MD, Hasan KM, Kibuule D, Banerjee R, McIntyre E, Nelson JA, Hahn T, Gendelman HE, Mosley RL (2007) Quantitative diffusion tensor imaging detects dopaminergic neuronal degeneration in a murine model of Parkinson’s disease. Neurobiol Dis 26(3):590–596
Chesselet MF (2008) In vivo alpha-synuclein overexpression in rodents: a useful model of Parkinson’s disease? Exp Neurol 209(1):22–27
Chesselet MF, Richter F, Zhu C, Magen I, Watson MB, Subramaniam SR (2012) A progressive mouse model of Parkinson’s disease: the Thy1-aSyn (“Line 61”) mice. Neurotherapeutics 9(2):297–314
Cheung JS, Wang E, Lo EH, Sun PZ (2012) Stratification of heterogeneous diffusion MRI ischemic lesion with kurtosis imaging: evaluation of mean diffusion and kurtosis MRI mismatch in an animal model of transient focal ischemia. Stroke 43(8):2252–2254
Cochrane CJ, Ebmeier KP (2013) Diffusion tensor imaging in parkinsonian syndromes: a systematic review and meta-analysis. Neurology 80(9):857–864
Delenclos M, Carrascal L, Jensen K, Romero-Ramos M (2014) Immunolocalization of human alpha-synuclein in the Thy1-aSyn (“Line 61”) transgenic mouse line. Neuroscience 277:647–664
Delgado y Palacios R, Campo A, Henningsen K, Verhoye M, Poot D, Dijkstra J, Van Audekerke J, Benveniste H, Sijbers J, Wiborg O, Van der Linden A (2011) Magnetic resonance imaging and spectroscopy reveal differential hippocampal changes in anhedonic and resilient subtypes of the chronic mild stress rat model. Biol Psychiatry 70(5):449–457
Falangola MF, Guilfoyle DN, Tabesh A, Hui ES, Nie X, Jensen JH, Gerum SV, Hu C, LaFrancois J, Collins HR, Helpern JA (2014) Histological correlation of diffusional kurtosis and white matter modeling metrics in cuprizone-induced corpus callosum demyelination. NMR Biomed 27(8):948–957
Fleming SM, Salcedo J, Fernagut PO, Rockenstein E, Masliah E, Levine MS, Chesselet MF (2004) Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein. J Neurosci 24(42):9434–9440
Fleming SM, Fernagut PO, Chesselet MF (2005) Genetic mouse models of parkinsonism: strengths and limitations. NeuroRx 2(3):495–503
Fleming SM, Salcedo J, Hutson CB, Rockenstein E, Masliah E, Levine MS, Chesselet MF (2006) Behavioral effects of dopaminergic agonists in transgenic mice overexpressing human wildtype alpha-synuclein. Neuroscience 142(4):1245–1253
Giannelli M, Toschi N, Passamonti L, Mascalchi M, Diciotti S, Tessa C (2012) Diffusion kurtosis and diffusion-tensor MR imaging in Parkinson disease. Radiology 265(2):645–646 author reply 6-7
Hui ES, Du F, Huang S, Shen Q, Duong TQ (2012) Spatiotemporal dynamics of diffusional kurtosis, mean diffusivity and perfusion changes in experimental stroke. Brain Res 1451:100–109
Jensen JH, Helpern JA (2010) MRI quantification of non-Gaussian water diffusion by kurtosis analysis. NMR Biomed 23(7):698–710
Jensen JH, Helpern JA, Ramani A, Lu H, Kaczynski K (2005) Diffusional kurtosis imaging: the quantification of non-gaussian water diffusion by means of magnetic resonance imaging. Magn Reson Med 53(6):1432–1440
Kamagata K, Tomiyama H, Motoi Y, Kano M, Abe O, Ito K, Shimoji K, Suzuki M, Hori M, Nakanishi A, Kuwatsuru R, Sasai K, Aoki S, Hattori N (2013) Diffusional kurtosis imaging of cingulate fibers in Parkinson disease: comparison with conventional diffusion tensor imaging. Magn Reson Imaging 31(9):1501–1506
Kamagata K, Tomiyama H, Hatano T, Motoi Y, Abe O, Shimoji K, Kamiya K, Suzuki M, Hori M, Yoshida M, Hattori N, Aoki S (2014) A preliminary diffusional kurtosis imaging study of Parkinson disease: comparison with conventional diffusion tensor imaging. Neuroradiology 56(3):251–258
Lang AE, Mikulis D (2009) A new sensitive imaging biomarker for Parkinson disease? Neurology 72(16):1374–1375
Leemans A, Jeurissen B, Sijbers J, Jones DK (2009) ExploreDTI: a graphical toolbox for processing, analyzing, and visualizing diffusion MR data. In: 17th Annual Meeting of Intl Soc Mag Reson Med, Hawaii, USA
Lerner A, Mogensen MA, Kim PE, Shiroishi MS, Hwang DH, Law M (2013) Clinical applications of diffusion tensor imaging. World Neurosurg 82(1–2):96–109
Meijer FJ, Goraj B (2014) Brain MRI in Parkinson’s disease. Front Biosci (Elite edition) 6:360–369
Paxinos G, Franklin K (2001) The mouse brain in stereotaxic coordinates, 2nd edn. Academic Press, San Diego
Pierpaoli C, Basser PJ (1996) Toward a quantitative assessment of diffusion anisotropy. Magn Reson Med 36(6):893–906
Rascol O, Lozano A, Stern M, Poewe W (2011) Milestones in Parkinson’s disease therapeutics. Mov Disord 26(6):1072–1082
Rolheiser TM, Fulton HG, Good KP et al (2011) Diffusion tensor imaging and olfactory identification testing in early stage Parkinson’s disease. J Neurol 258:1254–1260
Schintu N, Frau L, Ibba M, Garau A, Carboni E, Carta AR (2009) Progressive dopaminergic degeneration in the chronic MPTPp mouse model of Parkinson’s disease. Neurotox Res 16(2):127–139
Schwarz ST, Abaei M, Gontu V, Morgan PS, Bajaj N, Auer DP (2013) Diffusion tensor imaging of nigral degeneration in Parkinson’s disease: a region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis. Neuroimage Clin 3:481–488
Sgado P, Viaggi C, Pinna A, Marrone C, Vaglini F, Pontis S, Mercuri NB, Morelli M, Corsini GU (2011) Behavioral, neurochemical, and electrophysiological changes in an early spontaneous mouse model of nigrostriatal degeneration. Neurotox Res 20(2):170–181
Sierra A, Laitinen T, Lehtimäki K, Rieppo L, Pitkänen A, Gröhn O (2011) Diffusion tensor MRI with tract based spatial statistics and histology reveals undiscovered lesioned areas in kainate model of epilepsy in rat. Brain Struct Funct 216(2):123–135
Smith SM (2002) Fast robust automated brain extraction. Hum Brain Mapp 17(3):143–155
Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, Bannister PR, De Luca M, Drobnjak I, Flitney DE, Niazy RK, Saunders J, Vickers J, Zhang Y, De Stefano N, Brady JM, Matthews PM (2004) Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23(Suppl 1):S208–S219
Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE, Watkins KE, Ciccarelli O, Cader MZ, Matthews PM, Behrens TE (2006) Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 31(4):1487–1505
Soria G, Aguilar E, Tudela R, Mullol J, Planas AM, Marin C (2011) In vivo magnetic resonance imaging characterization of bilateral structural changes in experimental Parkinson’s disease: a T2 relaxometry study combined with longitudinal diffusion tensor imaging and manganese-enhanced magnetic resonance imaging in the 6-hydroxydopamine rat model. Eur J Neurosci 33:1551–1560
Steven AJ, Zhuo J, Melhem ER (2014) Diffusion kurtosis imaging: an emerging technique for evaluating the microstructural environment of the brain. AJR Am J Roentgenol 202(1):W26–W33
Stocchi F, Olanow CW (2013) Obstacles to the development of a neuroprotective therapy for Parkinson’s disease. Mov Disord 28(1):3–7
Suidan GL, Duerschmied D, Dillon GM, Vanderhorst V, Hampton TG, Wong SL, Voorhees JR, Wagner DD (2013) Lack of tryptophan hydroxylase-1 in mice results in gait abnormalities. PLoS One 8(3):e59032
Tillerson JL, Miller GW (2003) Grid performance test to measure behavioral impairment in the MPTP-treated-mouse model of parkinsonism. J Neurosci Methods 123(2):189–200
Vaillancourt DE, Spraker MB, Prodoehl J et al (2009) High resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology 72:1378–1384
Vanhoutte G, Pereson S, Delgado YPR, Guns PJ, Asselbergh B, Veraart J, Sijbers J, Verhoye M, Van Broeckhoven C, Van der Linden A (2013) Diffusion kurtosis imaging to detect amyloidosis in an APP/PS1 mouse model for Alzheimer’s disease. Magn Reson Med 69(4):1115–1121
Wang JJ, Lin WY, Lu CS, Weng YH, Ng SH, Wang CH, Liu HL, Hsieh RH, Wan YL, Wai YY (2011) Parkinson disease: diagnostic utility of diffusion kurtosis imaging. Radiology 261(1):210–217
Watson MB, Richter F, Lee SK, Gabby L, Wu J, Masliah E, Effros RB, Chesselet MF (2012) Regionally-specific microglial activation in young mice over-expressing human wild type alpha-synuclein. Exp Neurol 237(2):318–334
Zhuo J, Xu S, Proctor JL, Mullins RJ, Simon JZ, Fiskum G, Gullapalli RP (2012) Diffusion kurtosis as an in vivo imaging marker for reactive astrogliosis in traumatic brain injury. NeuroImage 59(1):467–477
Acknowledgments
The transgenic mice were supplied for free by the QPS Austria GmbH, Grambach, Austria. The instruments for behavioral tests were kindly provided by Jiri Kucera, Environmental Measuring Systems, Brno, Czech Republic. The authors are grateful to Amy Chen and Heejae Chung for helping with English proof reading. This work was supported by the project “Employment of Newly Graduated Doctors of Science for Scientific Excellence” (CZ.1.07/2.3.00/30.0009) co-financed from the European Social Fund and the state budget of the Czech Republic and by the project “CEITEC - Central European Institute of Technology” (CZ.1.05/1.1.00/02.0068) from the European Regional Development Fund. This study was also financed from the SoMoPro II programme. The research leading to this invention has acquired a financial grant from the People Programme (Marie Curie action) of the Seventh Framework Programme of EU according to the REA Grant Agreement No. 291782. The research is further co-financed by the South-Moravian Region. The study reflects only the author’s views and that the Union is not liable for any use that may be made of the information contained therein.The MR research was also supported by MEYS CR (LO1212), the MR unit and the animal facility (CZ62760225) infrastructure by MEYS CR and EC (CZ.1.05/2.1.00/01.0017) and by ASCR (RVO:68081731).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no ethical or financial conflict of interest.
Human and Animal Rights and Informed Consent
All procedures involving experimental animals were performed in accordance with EU Directive no. 2010/63/EU and approved by the Animal Care Committee of the Faculty of Medicine, Masaryk University, Czech Republic, in compliance with Czech Animal Protection Act No. 246/1992.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Khairnar, A., Latta, P., Drazanova, E. et al. Diffusion Kurtosis Imaging Detects Microstructural Alterations in Brain of α-Synuclein Overexpressing Transgenic Mouse Model of Parkinson’s Disease: A Pilot Study. Neurotox Res 28, 281–289 (2015). https://doi.org/10.1007/s12640-015-9537-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12640-015-9537-9